drugset / Trial / NCT03295058

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

NCT03295058

Phase 2/3 Unknown 50 enrolled Assiut University
RandomizedSingle-groupOpen-labelTreatment

Summary

Aplastic anemia is a syndrome of bone marrow failure characterized by peripheral pancytopenia and marrow hypoplasia.The theoretical basis for marrow failure includes primary defects in or damage to the stem cell or the marrow microenvironment

Timeline

Start
2019-01-01
Primary completion
2019-12-01
Completion
2020-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE) Protein / enzyme biologic
Subject Cyclophosphamide Other / unclassified 25 mg/kg
Subject Fludarabine Small molecule 120 mg/m2
Background Cyclosporine Peptide 3 mg/kg

Indications